The MRC Clinical Trials Unit (MRC CTU) at UCL is at the forefront of resolving internationally important questions in infectious diseases and cancer, and delivering swifter and more effective translation of scientific research into patient benefits. It does this by carrying out challenging and innovative studies, and developing and implementing methodological advances in study design, conduct and analysis.
We are committed to strengthening and expanding the evidence base for healthcare nationally and internationally.
The MRC CTU at UCL develops methodology to improve the design, conduct and analysis of clinical studies, and hosts one of the MRC’s six regional Hubs for Trials Methodology Research.
The MRC CTU at UCL is a UKCRC registered trials unit.
Read more about the Unit